Clinical Trial Update: EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study of EL625 in patients with persistent chronic lymphocytic leukemia or small lymphocytic lymphoma was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• EL625

Snippet

Sponsor: David Rizzieri | Conditions: Lymphoma, Small Lymphocytic, Leukemia, Lymphocytic, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2012-08-22